Thymosin Alpha-1 has genuine clinical use in some regions, but regulatory status varies and the others are largely preclinical. Immune modulation is not something to self-manage.
Peptides researched for this goal
An immune-modulating peptide used clinically in several countries.
The human cathelicidin antimicrobial peptide studied for immune defense.
A short tripeptide fragment of α-MSH studied for anti-inflammatory effects.
Frequently asked questions
Thymosin Alpha-1 is the most established immune-modulating peptide and is used clinically in several countries, though regulatory status varies.
Thymosin Alpha-1 is approved or used clinically in some countries; LL-37 and KPV are research compounds. Use under medical supervision.
Get a stack matched to your goals
Describe your situation and Selpho's free AI advisor will suggest research-backed peptides — no signup needed.
Try the Peptide AdvisorThis page is for educational purposes only and is not medical advice, a diagnosis, or a recommendation to use any compound. It contains no dosing or purchase information. Always consult a licensed healthcare professional before considering any peptide.